Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2026 98.24%
August 31, 2026 98.24%
July 31, 2026 98.24%
June 30, 2026 98.24%
May 31, 2026 98.24%
April 30, 2026 98.24%
March 31, 2026 98.24%
February 28, 2026 98.24%
January 31, 2026 98.24%
December 31, 2025 98.24%
November 30, 2025 98.24%
October 31, 2025 98.24%
September 30, 2025 98.24%
August 31, 2025 98.24%
July 31, 2025 98.24%
June 30, 2025 98.24%
May 31, 2025 98.24%
April 30, 2025 98.24%
March 31, 2025 98.24%
February 28, 2025 98.21%
January 31, 2025 98.14%
December 31, 2024 98.14%
November 30, 2024 98.14%
October 31, 2024 97.45%
September 30, 2024 97.10%
Date Value
August 31, 2024 96.82%
July 31, 2024 95.78%
June 30, 2024 94.74%
May 31, 2024 94.12%
April 30, 2024 94.06%
March 31, 2024 94.06%
February 29, 2024 94.06%
January 31, 2024 94.06%
December 31, 2023 94.06%
November 30, 2023 93.90%
October 31, 2023 93.90%
September 30, 2023 90.59%
August 31, 2023 90.21%
July 31, 2023 87.06%
June 30, 2023 87.06%
May 31, 2023 87.06%
April 30, 2023 87.06%
March 31, 2023 85.19%
February 28, 2023 80.53%
January 31, 2023 80.53%
December 31, 2022 80.53%
November 30, 2022 80.53%
October 31, 2022 80.53%
September 30, 2022 80.53%
August 31, 2022 80.53%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Repligen Corp. 68.27%
Bio-Techne Corp. 67.22%
BioLife Solutions, Inc. 85.14%
Maravai Lifesciences Holdings, Inc. 97.16%
MaxCyte, Inc. 96.07%